M&As this week: JHL Biotech, Bio Techne, Metabolon


JHL Biotech has acquired 40% stake in a biomedical company based in Wuhan, China, in a long-term investment pursuit.

The acquirer company is a biopharmaceutical company based in Taiwan.

US-based life science company Bio Techne has completed the acquisition of Trevigen.

The acquisition was completed in an all-cash transaction and is expected to complement the acquirer company’s product portfolio, as well as be accretive to its adjusted earnings per share in the next financial year.

"US-based life science company Bio Techne has completed the acquisition of Trevigen."

Also based in the US, the target company is a biotechnology company.

US-based health technology company Metabolon has acquired Metabolomic Discoveries, with the aim of advancing its European presence in metabolomics.

Based in Germany, the target company provides metabolomics and diagnostics services.